Clafoxy-S 2250 Injection
Marketer
Unifaith Biotech (P) Limited
Salt Composition
Cefuroxime (1500mg) + Sulbactam (750mg)
Overview Clafoxy-S 2250 Injection
Clafoxy-S 2250 Injection, a dual-action antibiotic, combats diverse bacterial infections by inhibiting microbial proliferation and halting infection spread. Administration must be solely under a physician's guidance. Strict adherence to the prescribed dosage schedule is crucial; premature cessation may compromise efficacy. Complete the entire course of treatment, even with symptom improvement. Typical side effects include nausea, vomiting, diarrhea, and dyspepsia. Report worsening side effects immediately to your doctor. Seek urgent medical attention for allergic reactions (skin rash, itching, edema, respiratory distress). Inform your doctor of all current medications, including those for pre-existing conditions, before commencing treatment. Pregnant or lactating individuals should consult their physician prior to use. Alcohol consumption should be avoided due to potential additive drowsiness. While usually non-impairing, refrain from driving if experiencing drowsiness or dizziness. Adequate rest, balanced nutrition, and sufficient hydration contribute to optimal recovery. Your doctor may order laboratory tests to monitor treatment response.
Primary Ingredients of Clafoxy-S 2250 Injection
No text provided. Please provide the text you wish me to rephrase.
Uses of Clafoxy-S 2250 Injection
Infections caused by bacteria
Major Benefits of Clafoxy-S 2250 Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Clafoxy-S 2250 Injection:
- Nausea
- Vomiting
- Diarrhea
- Increased liver enzymes
- Allergic reaction
How to use Clafoxy-S 2250 Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
How Clafoxy-S 2250 Injection works:
Clafoxy-S 2250 Injection unites Cefuroxime, an antibiotic, with Sulbactam, a beta-lactamase inhibitor. Cefuroxime combats bacterial infection by disrupting the synthesis of their protective outer layer, crucial for their survival within the host. Sulbactam's role is to neutralize bacterial enzymes that would otherwise deactivate Cefuroxime, thus bolstering its effectiveness and overcoming bacterial resistance.
SAFETY ADVICE
AlcoholSAFE
Concurrent use of Clafoxy-S 2250 Injection and alcohol does not produce adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Clafoxy-S 2250 is typically deemed safe for use during gestation. Preclinical trials using animals revealed minimal or no negative impacts on fetal development; however, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Clafoxy-S 2250 Injection presents minimal risk during lactation. Research in humans indicates negligible transfer into breast milk, posing no discernible threat to the infant.
DrivingNOT RELEVANT
Clafoxy-S 2250 Injection is exclusively administered in a hospital setting.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Clafoxy-S 2250 Injection use in individuals with renal impairment. Seek medical advice from your physician.
LiverCONSULT YOUR DOCTOR
Data regarding Clafoxy-S 2250 Injection use in individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Clafoxy-S 2250 Injection :
Should you forget a scheduled Clafoxy-S 2250 Injection, seek medical advice.
Facts to Know About Clafoxy-S 2250 Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
3,018 People bought this recently